Advertisement

Index by author

November 01, 1994; Volume 46,Issue 5

A

  1. Ahluwalia, G S

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

B

  1. Banfi, P

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  2. Barker, E L

    1. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
      E L Barker, H L Kimmel and R D Blakely
      Molecular Pharmacology November 1994, 46 (5) 799-807;

  3. Barone, L R

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  4. Belelli, D

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

  5. Berleth, E

    1. Doxorubicin-induced DNA degradation in murine thymocytes.
      G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
      Molecular Pharmacology November 1994, 46 (5) 901-908;

  6. Blakely, R D

    1. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
      E L Barker, H L Kimmel and R D Blakely
      Molecular Pharmacology November 1994, 46 (5) 799-807;

  7. Blumberg, P M

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

  8. Bossé, R

    1. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
      C Liebmann, R Bossé and E Escher
      Molecular Pharmacology November 1994, 46 (5) 949-956;

  9. Buller, A L

    1. Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
      A L Buller, G A Hastings, E F Kirkness and C M Fraser
      Molecular Pharmacology November 1994, 46 (5) 858-865;

C

  1. Chapman, K L

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  2. Chiappinelli, V A

    1. Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan.
      W R Weaver, K M Wolf and V A Chiappinelli
      Molecular Pharmacology November 1994, 46 (5) 993-1001;

  3. Cooney, D A

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

  4. Coutsogeorgopoulos, C

    1. New aspects of the kinetics of inhibition by lincomycin of peptide bond formation.
      S Kallia-Raftopoulos, D L Kalpaxis and C Coutsogeorgopoulos
      Molecular Pharmacology November 1994, 46 (5) 1009-1014;

D

  1. Denning, M F

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

  2. Dlugosz, A A

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

  3. Dragani, T A

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  4. Driscoll, J S

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

E

  1. Ebert, B

    1. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
      B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
      Molecular Pharmacology November 1994, 46 (5) 957-963;

  2. Eger, E I

    1. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
      S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
      Molecular Pharmacology November 1994, 46 (5) 851-857;

  3. Ehrke, M J

    1. Doxorubicin-induced DNA degradation in murine thymocytes.
      G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
      Molecular Pharmacology November 1994, 46 (5) 901-908;

  4. Elliot, M

    1. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
      M F Miles, N Wilke, M Elliot, W Tanner and S Shah
      Molecular Pharmacology November 1994, 46 (5) 873-879;

  5. Esbenshade, T A

    1. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
      K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
      Molecular Pharmacology November 1994, 46 (5) 929-936;

  6. Escher, E

    1. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
      C Liebmann, R Bossé and E Escher
      Molecular Pharmacology November 1994, 46 (5) 949-956;

F

  1. Falvella, F S

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  2. Farber, J L

    1. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
      K Mizumoto, R J Rothman and J L Farber
      Molecular Pharmacology November 1994, 46 (5) 890-895;

  3. Fletcher, A E

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  4. Fraser, C M

    1. Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
      A L Buller, G A Hastings, E F Kirkness and C M Fraser
      Molecular Pharmacology November 1994, 46 (5) 858-865;

G

  1. Gaivin, R

    1. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
      D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
      Molecular Pharmacology November 1994, 46 (5) 823-831;

  2. Gambetta, R A

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  3. Gariboldi, M

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  4. Gipp, J J

    1. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
      R T Mulcahy, S Untawale and J J Gipp
      Molecular Pharmacology November 1994, 46 (5) 909-914;

  5. Glover, E

    1. Analysis of the four alleles of the murine aryl hydrocarbon receptor.
      A Poland, D Palen and E Glover
      Molecular Pharmacology November 1994, 46 (5) 915-921;

  6. Graham, R M

    1. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
      D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
      Molecular Pharmacology November 1994, 46 (5) 823-831;

  7. Gusovsky, F

    1. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
      M Vanek, L D Hawkins and F Gusovsky
      Molecular Pharmacology November 1994, 46 (5) 832-839;

H

  1. Hall, Z W

    1. Amino- and carboxyl-terminal domains specify the identity of the delta subunit in assembly of the mouse muscle nicotinic acetylcholine receptor.
      X M Yu and Z W Hall
      Molecular Pharmacology November 1994, 46 (5) 964-969;

  2. Han, C

    1. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
      K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
      Molecular Pharmacology November 1994, 46 (5) 929-936;

  3. Hargreaves, R J

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  4. Harris, R A

    1. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
      S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
      Molecular Pharmacology November 1994, 46 (5) 851-857;

  5. Hastings, G A

    1. Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
      A L Buller, G A Hastings, E F Kirkness and C M Fraser
      Molecular Pharmacology November 1994, 46 (5) 858-865;

  6. Hawkins, L D

    1. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
      M Vanek, L D Hawkins and F Gusovsky
      Molecular Pharmacology November 1994, 46 (5) 832-839;

  7. Hawkinson, J E

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

  8. Hollinger, S

    1. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
      K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
      Molecular Pharmacology November 1994, 46 (5) 929-936;

I

  1. Ichimura, M

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  2. Ionescu, P

    1. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
      S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
      Molecular Pharmacology November 1994, 46 (5) 851-857;

  3. Iversen, L L

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  4. Iversen, S D

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

J

  1. Johns, D G

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

  2. Juchau, M R

    1. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
      H Y Yang, Q P Lee, A E Rettie and M R Juchau
      Molecular Pharmacology November 1994, 46 (5) 922-928;

K

  1. Kallia-Raftopoulos, S

    1. New aspects of the kinetics of inhibition by lincomycin of peptide bond formation.
      S Kallia-Raftopoulos, D L Kalpaxis and C Coutsogeorgopoulos
      Molecular Pharmacology November 1994, 46 (5) 1009-1014;

  2. Kalpaxis, D L

    1. New aspects of the kinetics of inhibition by lincomycin of peptide bond formation.
      S Kallia-Raftopoulos, D L Kalpaxis and C Coutsogeorgopoulos
      Molecular Pharmacology November 1994, 46 (5) 1009-1014;

  3. Kase, H

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  4. Kemp, J A

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;
    2. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
      B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
      Molecular Pharmacology November 1994, 46 (5) 957-963;

  5. Kimbrough, C L

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

  6. Kimmel, H L

    1. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
      E L Barker, H L Kimmel and R D Blakely
      Molecular Pharmacology November 1994, 46 (5) 799-807;

  7. Kirkness, E F

    1. Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
      A L Buller, G A Hastings, E F Kirkness and C M Fraser
      Molecular Pharmacology November 1994, 46 (5) 858-865;

  8. Krogsgaard-Larsen, P

    1. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
      B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
      Molecular Pharmacology November 1994, 46 (5) 957-963;

L

  1. Laing, N

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  2. Lambert, J J

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

  3. Lan, N C

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

  4. Lanzi, C

    1. The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
      P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
      Molecular Pharmacology November 1994, 46 (5) 896-900;

  5. Lee, Q P

    1. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
      H Y Yang, Q P Lee, A E Rettie and M R Juchau
      Molecular Pharmacology November 1994, 46 (5) 922-928;

  6. Liebmann, C

    1. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
      C Liebmann, R Bossé and E Escher
      Molecular Pharmacology November 1994, 46 (5) 949-956;

M

  1. Malik, N

    1. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
      D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
      Molecular Pharmacology November 1994, 46 (5) 823-831;

  2. Marshall, G R

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  3. McQuilkin, S J

    1. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
      S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
      Molecular Pharmacology November 1994, 46 (5) 851-857;

  4. Mihic, S J

    1. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
      S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
      Molecular Pharmacology November 1994, 46 (5) 851-857;

  5. Mihich, E

    1. Doxorubicin-induced DNA degradation in murine thymocytes.
      G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
      Molecular Pharmacology November 1994, 46 (5) 901-908;

  6. Miles, M F

    1. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
      M F Miles, N Wilke, M Elliot, W Tanner and S Shah
      Molecular Pharmacology November 1994, 46 (5) 873-879;

  7. Minneman, K P

    1. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
      K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
      Molecular Pharmacology November 1994, 46 (5) 929-936;

  8. Mitsuya, H

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

  9. Mizumoto, K

    1. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
      K Mizumoto, R J Rothman and J L Farber
      Molecular Pharmacology November 1994, 46 (5) 890-895;

  10. Mori, A

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  11. Mulcahy, R T

    1. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
      R T Mulcahy, S Untawale and J J Gipp
      Molecular Pharmacology November 1994, 46 (5) 909-914;

N

  1. Nakamura, K

    1. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
      F Ushikubi, K Nakamura and S Narumiya
      Molecular Pharmacology November 1994, 46 (5) 808-816;

  2. Narumiya, S

    1. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
      F Ushikubi, K Nakamura and S Narumiya
      Molecular Pharmacology November 1994, 46 (5) 808-816;

  3. Nonaka, H

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

P

  1. Palen, D

    1. Analysis of the four alleles of the murine aryl hydrocarbon receptor.
      A Poland, D Palen and E Glover
      Molecular Pharmacology November 1994, 46 (5) 915-921;

  2. Patel, S

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  3. Perez, D M

    1. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
      D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
      Molecular Pharmacology November 1994, 46 (5) 823-831;

  4. Pettit, G R

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

  5. Piascik, M T

    1. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
      D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
      Molecular Pharmacology November 1994, 46 (5) 823-831;

  6. Poland, A

    1. Analysis of the four alleles of the murine aryl hydrocarbon receptor.
      A Poland, D Palen and E Glover
      Molecular Pharmacology November 1994, 46 (5) 915-921;

  7. Purdy, R H

    1. Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
      J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
      Molecular Pharmacology November 1994, 46 (5) 977-985;

R

  1. Racagni, G

    1. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
      A Volterra, D Trotti and G Racagni
      Molecular Pharmacology November 1994, 46 (5) 986-992;

  2. Rane, S G

    1. Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor.
      W A Twitchell and S G Rane
      Molecular Pharmacology November 1994, 46 (5) 793-798;

  3. Rettie, A E

    1. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
      H Y Yang, Q P Lee, A E Rettie and M R Juchau
      Molecular Pharmacology November 1994, 46 (5) 922-928;

  4. Robbins, J D

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  5. Rothman, R J

    1. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
      K Mizumoto, R J Rothman and J L Farber
      Molecular Pharmacology November 1994, 46 (5) 890-895;

  6. Ryecroft, W

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

S

  1. Sanders-Bush, E

    1. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
      R S Westphal and E Sanders-Bush
      Molecular Pharmacology November 1994, 46 (5) 937-942;

  2. Scammell, J G

    1. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
      M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
      Molecular Pharmacology November 1994, 46 (5) 880-889;

  3. Seamon, K B

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  4. Shah, S

    1. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
      M F Miles, N Wilke, M Elliot, W Tanner and S Shah
      Molecular Pharmacology November 1994, 46 (5) 873-879;

  5. Shimada, J

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  6. Shindou, T

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  7. Shirasaka, T

    1. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
      G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
      Molecular Pharmacology November 1994, 46 (5) 1002-1008;

  8. Smith, A J

    1. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
      S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
      Molecular Pharmacology November 1994, 46 (5) 943-948;

  9. Smith, C B

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

  10. Speicher, L A

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  11. Strada, S J

    1. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
      M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
      Molecular Pharmacology November 1994, 46 (5) 880-889;

  12. Szallasi, Z

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

T

  1. Tanner, W

    1. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
      M F Miles, N Wilke, M Elliot, W Tanner and S Shah
      Molecular Pharmacology November 1994, 46 (5) 873-879;

  2. Tew, K D

    1. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
      L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
      Molecular Pharmacology November 1994, 46 (5) 866-872;

  3. Theroux, T L

    1. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
      K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
      Molecular Pharmacology November 1994, 46 (5) 929-936;

  4. Thompson, M E

    1. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
      M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
      Molecular Pharmacology November 1994, 46 (5) 880-889;

  5. Trotti, D

    1. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
      A Volterra, D Trotti and G Racagni
      Molecular Pharmacology November 1994, 46 (5) 986-992;

  6. Twitchell, W A

    1. Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor.
      W A Twitchell and S G Rane
      Molecular Pharmacology November 1994, 46 (5) 793-798;

U

  1. Untawale, S

    1. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
      R T Mulcahy, S Untawale and J J Gipp
      Molecular Pharmacology November 1994, 46 (5) 909-914;

  2. Ushikubi, F

    1. Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
      F Ushikubi, K Nakamura and S Narumiya
      Molecular Pharmacology November 1994, 46 (5) 808-816;

V

  1. Valentine, D L

    1. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
      M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
      Molecular Pharmacology November 1994, 46 (5) 880-889;

  2. Vanek, M

    1. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
      M Vanek, L D Hawkins and F Gusovsky
      Molecular Pharmacology November 1994, 46 (5) 832-839;

  3. Verstovsek, S

    1. Doxorubicin-induced DNA degradation in murine thymocytes.
      G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
      Molecular Pharmacology November 1994, 46 (5) 901-908;

  4. Volterra, A

    1. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
      A Volterra, D Trotti and G Racagni
      Molecular Pharmacology November 1994, 46 (5) 986-992;

W

  1. Wafford, K A

    1. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
      B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
      Molecular Pharmacology November 1994, 46 (5) 957-963;

  2. Wagner, J A

    1. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
      M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
      Molecular Pharmacology November 1994, 46 (5) 880-889;

  3. Weaver, W R

    1. Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan.
      W R Weaver, K M Wolf and V A Chiappinelli
      Molecular Pharmacology November 1994, 46 (5) 993-1001;

  4. Westphal, R S

    1. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
      R S Westphal and E Sanders-Bush
      Molecular Pharmacology November 1994, 46 (5) 937-942;

  5. Whiting, P J

    1. Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
      B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
      Molecular Pharmacology November 1994, 46 (5) 957-963;

  6. Wilke, N

    1. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
      M F Miles, N Wilke, M Elliot, W Tanner and S Shah
      Molecular Pharmacology November 1994, 46 (5) 873-879;

  7. Wolf, K M

    1. Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan.
      W R Weaver, K M Wolf and V A Chiappinelli
      Molecular Pharmacology November 1994, 46 (5) 993-1001;

Y

  1. Yanagawa, K

    1. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
      H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
      Molecular Pharmacology November 1994, 46 (5) 817-822;

  2. Yang, H Y

    1. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
      H Y Yang, Q P Lee, A E Rettie and M R Juchau
      Molecular Pharmacology November 1994, 46 (5) 922-928;

  3. Yool, A J

    1. Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
      A J Yool
      Molecular Pharmacology November 1994, 46 (5) 970-976;

  4. Yu, X M

    1. Amino- and carboxyl-terminal domains specify the identity of the delta subunit in assembly of the mouse muscle nicotinic acetylcholine receptor.
      X M Yu and Z W Hall
      Molecular Pharmacology November 1994, 46 (5) 964-969;

  5. Yuspa, S H

    1. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
      Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
      Molecular Pharmacology November 1994, 46 (5) 840-850;

Z

  1. Zaleskis, G

    1. Doxorubicin-induced DNA degradation in murine thymocytes.
      G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
      Molecular Pharmacology November 1994, 46 (5) 901-908;
Back to top

In this issue

Advertisement